Evidence map›Paper›PMID 36949070›Full record

ArticleNature communications2023

Integrated analysis of genomic and transcriptomic data for the discovery of splice-associated variants in cancer.

Kelsy C Cotto, Yang-Yang Feng, Avinash Ramu, Megan Richters, Sharon L Freshour, Zachary L Skidmore, Huiming Xia, Joshua F McMichael, Jason Kunisaki, Katie M Campbell and 14 more

Open access · goldFull text read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 106 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
106citing papers in PubMed, 1 pooled it
26.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

106 citing papers in PubMed, 1 synthesis or guideline pooled it, 123 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Improving splice site usage prediction with SPLAIRE.bioRxiv : the preprint server for biology · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. ASPECT: Alternative Splicing Event Classification with Transformers.bioRxiv : the preprint server for biology · 2026
    Article
  20. Article

46 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 4 institutions in 1 country.

Kelsy C Cotto *Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.ORCID 0000-0003-0890-6889
Yang-Yang Feng *McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO, USA.ORCID 0000-0002-6347-6749
Avinash RamuDepartment of Genetics, Washington University School of Medicine, St. Louis, MO, USA.
Megan RichtersDivision of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.ORCID 0000-0002-5491-2537
Sharon L FreshourDivision of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
Zachary L SkidmoreDivision of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
Huiming XiaDivision of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.ORCID 0000-0003-2571-1880
Joshua F McMichaelMcDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO, USA.ORCID 0000-0002-0197-2245
Jason KunisakiMcDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO, USA.
Katie M CampbellDivision of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.ORCID 0000-0001-6491-4432
Timothy Hung-Po ChenDivision of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
Emily B RozyckiDivision of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
Douglas AdkinsDivision of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
Siddhartha DevarakondaDivision of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
Sumithra SankararamanDivision of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
Yiing LinDepartment of Surgery, Washington University School of Medicine, St. Louis, MO, USA.ORCID 0000-0002-0317-7608
William C ChapmanDepartment of Surgery, Washington University School of Medicine, St. Louis, MO, USA.
Christopher A MaherDivision of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.ORCID 0000-0002-9035-603X
Vivek AroraDivision of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.ORCID 0000-0003-1694-9109
Gavin P DunnDepartment of Neurosurgery, Mass General Hospital, Boston, MA, USA.
Ravindra UppaluriDepartment of Surgery, Brigham and Women's Hospital, Boston, MA, USA.ORCID 0000-0001-5988-6828
Ramaswamy GovindanDivision of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.ORCID 0000-0002-6964-9612
Obi L GriffithDivision of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA. obigriffith@wustl.edu.ORCID 0000-0002-0843-4271
Malachi GriffithDivision of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA. mgriffit@wustl.edu.ORCID 0000-0002-6388-446X
Washington University in St. Louis · USJames S. McDonnell Foundation · USBrigham and Women's Hospital · USMassachusetts General Hospital · US

Funding

Washington University SPORE in Pancreatic CancerP50CA272213 · NCI · WASHINGTON UNIVERSITY · PI David G DeNardo, WILLIAM G HAWKINS · 2023 to 2026
$10.7M
MOLECULAR ONCOLOGY TRAINING GRANTT32CA113275 · NCI · WASHINGTON UNIVERSITY · PI Matthew J Walter · 2006 to 2026
$5.7M
Standardized and Genome-Wide Clinical Interpretation of Complex Genotypes for Cancer Precision MedicineU24CA237719 · NCI · WASHINGTON UNIVERSITY · PI GRIFFITH, OBI L. · 2019 to 2023
$3.8M
Genomic and Functional Identification of Chemotherapy Resistance Mechanisms in Small Cell Lung CancerU01CA231844 · NCI · WASHINGTON UNIVERSITY · PI GOVINDAN, RAMASWAMY, GRIFFITH, OBI L. · 2018 to 2022
$3.1M
Informatics tools for identification, prioritization and clinical application of neoantigensU01CA248235 · NCI · WASHINGTON UNIVERSITY · PI GRIFFITH, MALACHI · 2020 to 2022
$1.3M
DEVELOPMENT OF INFORMATICS RESOURCES FOR INTERPRETATION OF CLINICALLY ACTIONABLE VARIANTS IN CANCERU01CA209936 · NCI · WASHINGTON UNIVERSITY · PI GRIFFITH, OBI L. · 2016 to 2018
$1.0M
Integrated Analysis & Interpretation of Whole Genome Exome & Transcriptome SequenR00HG007940 · NHGRI · WASHINGTON UNIVERSITY · PI GRIFFITH, MALACHI · 2017 to 2019
$724k
NCI NIH HHS P50 CA272213NCI NIH HHS T32 CA113275NCI NIH HHS U01 CA209936NCI NIH HHS U01 CA231844NCI NIH HHS U01 CA248235NCI NIH HHS U24 CA237719NHGRI NIH HHS R00 HG007940
6 · The paper itself

Abstract

Somatic mutations within non-coding regions and even exons may have unidentified regulatory consequences that are often overlooked in analysis workflows. Here we present RegTools ( www.regtools.org ), a computationally efficient, free, and open-source software package designed to integrate somatic variants from genomic data with splice junctions from bulk or single cell transcriptomic data to identify variants that may cause aberrant splicing. We apply RegTools to over 9000 tumor samples with both tumor DNA and RNA sequence data. RegTools discovers 235,778 events where a splice-associated variant significantly increases the splicing of a particular junction, across 158,200 unique variants and 131,212 unique junctions. To characterize these somatic variants and their associated splice isoforms, we annotate them with the Variant Effect Predictor, SpliceAI, and Genotype-Tissue Expression junction counts and compare our results to other tools that integrate genomic and transcriptomic data. While many events are corroborated by the aforementioned tools, the flexibility of RegTools also allows us to identify splice-associated variants in known cancer drivers, such as TP53, CDKN2A, and B2M, and other genes.

Indexed as

NeoplasmsTranscriptomeAlternative SplicingGenomeGenomicsHumansRNA Splicing

Identifiers

PMID36949070
PMCPMC10033906
OpenAlexW4353062956

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read54
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.